Tag: ASEAN

ALBANY, N.Y., Dec. 15, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced that Gerald Auer has been appointed as chief financial officer. He will join the organization effective Jan. 1, 2024.

“I am delighted to welcome Gerald to Curia as we head into the new year,” said Curia CEO Philip Macnabb. “Gerald brings extensive experience leading finance divisions with an impressive track record for success. I am confident that he will be an invaluable asset to our team and will help position us for a strong year in 2024.”

Auer most recently served as CFO at Al Dahra, a company specializing in agribusiness. Prior to his time at Al Dahra, Auer was CFO of the EMEA crop science division at Bayer, a life science company focused on health care and agriculture, and CFO of Bayer Switzerland. He spent more than 20 years at Bayer and held multiple leadership roles within its finance department, leading finance functions across the global organization in the North and Latin America region as well as Europe, the Middle East and Africa. Auer studied at the University of Marburg in Germany where he earned his master’s degree in business administration.

He currently resides in Basel, Switzerland with his family, but they plan to relocate to Raleigh, North Carolina in 2024.

“Curia is a dynamic company in the CDMO space with an inspirational mission to improve patients’ lives,” said Auer. “I look forward to collaborating with the talented team at Curia to help drive that mission for our customers and their patients.”

About Curia

Curia is a leading contract research, development, and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers. Curia’s nearly 4,000 employees at 27 locations across the U.S., Europe, and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.

Curia Contact Information:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8995447

The world’s leading boat rental platform launches a new solution for charter businesses to streamline payments and scheduling for just 1.5%

Getmyboat Launches Direct Booking Feature

The world’s leading boat rental platform launches a new solution for charter businesses to streamline payments and scheduling for just 1.5%

MENLO PARK, Calif., Dec. 14, 2023 (GLOBE NEWSWIRE) — Getmyboat, the world’s leading booking platform for yacht charters and boat rentals, is thrilled to announce the launch of its Direct Booking feature.

While consulting with partners of boating businesses of all sizes, Getmyboat discovered that many owners shared struggles in managing bookings from off-platform sources, including payment processing issues like fraud and chargebacks, claims management, fees for accepting credit payments, scheduling, renter communication and more which led to organizational headaches. To remedy these challenges, Getmyboat is focused on building a comprehensive software solution specifically designed for boat rental, yacht charter, and boat tour companies, and is constantly introducing new ways for owners to manage their entire business. The launch of Direct Booking on the Getmyboat app is a major first step in streamlining booking management, all for just 1.5%, which is among the lowest rates in the industry. Whether through their own websites, by email, Facebook, phone calls, or in person – Getmyboat owners can now take all leads and seamlessly turn them into bookings making it easier for them and their customers.

Key Benefits of Getmyboat’s Direct Booking

Unified Management: Boat owners can now consolidate all bookings, regardless of the source, into one comprehensive platform, eliminating the need for multiple software solutions and calendars.

Simplified Offers and Payment Processing: With a few simple steps, owners can send out offers, securely collect payments including credit cards, and automatically synchronize bookings with their overall calendar, ensuring a hassle-free transaction process for both the owner and renter.

Fraud Protection and Dispute Resolution: Direct Booking benefits from Getmyboat’s robust software, providing owners with fraud protection, claims process management, and efficient dispute resolution for all transactions.

Low Cost: Boating businesses only pay 1.5% per transaction to use the service. Not only does this cover credit card fees, but includes all the other integration features above.

Frank D, a fleet owner in Miami, expressed his enthusiasm, stating, “I’m really excited to use this new feature. Now, I will be able to see everything in one place, communicate with my clients on a single platform, and collect payments simply. And I’ll know where all my boats are supposed to be no matter where the customer came from originally.”

Bryan Petro, Getmyboat President, shared “We’re thrilled to bring Direct Booking to our partners. We know they have a tremendously hard job on the logistics side of the business, and we can take what we’ve built and extend it to everyone to help their businesses grow.”

Getmyboat owners can easily get started by opening the app or website, navigating to their inbox, and clicking on the “Add a Direct Booking” option. From there, they can enter customer and trip information, streamlining their management processes directly within their Getmyboat account.

As the top source of customers for boating businesses globally, Getmyboat continues to innovate to address the challenges faced by owners in managing their business across various platforms and is on a mission to provide the best growth tools in the industry.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d68cd4be-e68b-45b8-8caa-b31733c18679

For further information, please contact:

Val Streif
Getmyboat
[email protected]
+1 612-298-2535

GlobeNewswire Distribution ID 8994552

Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships

DURHAM, N.C., Dec. 13, 2023 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it convened last week the inaugural meeting of its Site Advisory Board, a collaboration between clinical research investigator sites (“sites”) and industry leaders to create a better clinical trial experience for sites, patients and clinical study sponsors (“sponsors”) by targeting changes in technology, operational planning and delivery, commercial terms and community engagement.

Fortrea places sites and investigators at the forefront of clinical trial planning, leveraging their perspectives to drive changes that will improve the speed of trial execution, ease study start up and increase recruitment efficiency. These changes address long-standing challenges within clinical trials and will result in a better site, patient and sponsor trial experience. The Site Advisory Board will be responsible for providing insight and feedback on strategies and solutions proposed regarding sites, patients, trial operations and relevant technology.

“Sites and investigators are critical to the industry at every stage of clinical development, and they traditionally have faced hard-to-solve challenges in clinical trials alone. We welcome their insights in protocol design and actively engage them in early conversations with our operational teams and sponsors to quickly establish the most efficient, patient-focused trial plans,” said Mike Clay, vice president, Development Strategy and Growth, at Fortrea. “The formation of the Site Advisory Board marks an acceleration of our site-focused strategy and includes representation from incredibly impressive leaders, creating a think tank for our industry. The Board will also serve as a cornerstone of our ability to respond to sponsors with insights that improve the predictability of their trials, working together to develop efficient operational plans and provide sponsors with a high degree of confidence in speed of patient recruitment and overall trial delivery.”

Inaugural members of Fortrea’s Site Advisory Board include leaders and experts from Circuit Clinical, Elligo Health Research, FutureMeds, Javara, MD Anderson Cancer Center Foundation Spain, ObjectiveHealth, Pratia S.A. and Velocity Clinical Research, representing 440 sites across more than 25 therapeutic areas and nine countries and providing access to diverse patient communities.

What Fortrea’s Site Advisory Board members are saying…

“We firmly believe that this collaborative approach, bringing together both CRO and sites, will enable all stakeholders to align more effectively on perspectives within the clinical trial market,” said Łukasz Bęczkowski, chief operating officer at Pratia. “This, undoubtedly, empowers us to act together in a more efficient manner. Initiatives like these play a crucial role in propelling us all towards positive and expedited changes.”

“Fortrea is taking a ‘listen first’ approach by giving sites an equal voice towards the most effective working practices for dynamic patient communities and site stakeholders, leading to the best service to clinical trial sponsors,” said Nick Spittal, chief operations officer at Velocity Clinical Research.

“Fortrea is leading the industry in making partnerships more productive and efficient, from trial process to business relationships, all in the effort to accelerate new products to market,” said Barry Simms, chief operating officer at Elligo Health Research.

“Providing the appropriate patient access solution is vital in determining the ultimate success of a clinical trial. Historically, care providers have not been involved in the early development of research planning and strategy,” said Colleen Hoke, chief executive officer at ObjectiveHealth. “We are very supportive of Fortrea employing an innovative new approach to engage with healthcare site partnership providers, who are key to delivering successful research results, early in the planning process.”

“FutureMeds is delighted to join the Fortrea Site Advisory Board to build better understanding between key stakeholders in the clinical research industry,” said Radek Janiak, chief executive officer at FutureMeds. “Hearing the voice of patients, investigators and sites will put Fortrea in a pole position for bringing new therapies to the market.”

“Working across the vast clinical trial ecosystem is complex and requires highly functional partnerships centered on trust and competence,” said Michelle Rule, senior vice president of enterprise optimization at Javara. “Fortrea’s genuine commitment to building a forum and working relationships through the Site Advisory Board exhibits dedication to progress for all stakeholders in research and, most of all, the patients.”

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of about 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter) @Fortrea.

Fortrea Contacts:
Fortrea Media: Galen Wilson – 703-298-0802, [email protected]
Fortrea Media: Kate Dillon – 646-818-9115, [email protected]

GlobeNewswire Distribution ID 8994021